Antiviral Drugs Market by Drug Class (Polymerase Inhibitors, Protease Inhibitors), By Disease Indication (Hepatitis, Human Immuno Deficiency Virus {HIV}, Influenza and others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Oct 2024
- Report ID: 97163
- Number of Pages: 380
- Format:
-
-
-
- Gilead Sciences Inc.
- AbbVie, Inc.
- GlaxoSmithKline
- Merck& C.O., Inc.
- Jannssen Pharmaceuticals, Inc.
- Bristol- Meyrs Squibb Company
- Mylan N. V.
- Novartis AG Company Profile
- AstraZeneca Plc Company Profile
- Pfizer Inc Company Profile
- Cipla Inc.
- Johnson & Johnson Services, Inc.
- Aurobindo Pharma
- Merck MRK
- Reddy Laboratories Limited
- Hoffmann-La Roche Ltd.
- Altesa Biosciences Inc.
- Other Key Players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible